Name: UMIN ID:
Unique ID issued by UMIN | UMIN000007274 |
---|---|
Receipt number | R000008468 |
Scientific Title | Investigation of usability of combination therapy with S-1 plus panitumumab in patients with KRAS wild type unresectable advanced and recurrent colorectal cancer, who had previously received on fluoropyrimidine, oxaliplatin and irinotecan ; phase II study. |
Date of disclosure of the study information | 2012/02/17 |
Last modified on | 2017/04/30 18:35:15 |
No. | Disposal | Last modified on | Item of update | |
---|---|---|---|---|
1 | Insert | 2012/02/13 11:09:38 | ||
2 | Update | 2012/02/14 11:38:19 | Key exclusion criteria |
|
3 | Update | 2012/02/14 11:40:37 | Date of protocol fixation |
|
4 | Update | 2012/05/29 11:45:52 | Recruitment status Date of protocol fixation Anticipated trial start date |
|
5 | Update | 2012/09/13 12:08:55 | Institutions |
|
6 | Update | 2013/02/13 09:13:07 | Institutions |
|
7 | Update | 2013/08/13 17:38:04 | Institutions |
|
8 | Update | 2013/08/14 15:44:38 | UMIN ID1 |
|
9 | Update | 2014/02/13 13:11:55 | TEL Last name of contact person Last name of contact person TEL Institutions |
|
10 | Update | 2014/08/13 09:21:33 | Email Institutions |
|
11 | Update | 2014/09/13 09:17:17 | Public title Public title |
|
12 | Update | 2014/09/13 09:21:45 | Institutions |
|
13 | Update | 2015/02/13 11:05:02 | Key exclusion criteria |
|
14 | Update | 2015/02/13 11:05:52 | Recruitment status |
|
15 | Update | 2015/05/22 08:11:07 | Email Email1 |
|
16 | Update | 2016/02/24 19:15:39 | Acronym Acronym |
|
17 | Update | 2016/08/17 09:08:42 | Name of primary person or sponsor Organization |
|
18 | Update | 2017/04/30 18:35:15 | Recruitment status Results Results |